Personal record-keeping and educational reference. 18+. The app does not recommend substances, doses or treatment, or determine whether a substance is safe, approved or appropriate for you. Consult a qualified healthcare professional about decisions involving your health.
‹ Library

SS-31 (Elamipretide)

Mitochondrial & MetabolicResearch Use Only

Also known as: Elamipretide, MTP-131, Bendavia, SS-31

A mitochondria-targeting peptide (approved for one rare disease) studied for cellular energy and heart/muscle function.

Dosing quick reference

research reference
Starting dose
5 mg once daily
Frequency
Once daily
Typical range
5–10 mg per day
Cycle
8–12 weeks
Titration (step-up)
Wk 1–2: 5 mg → Wk 3+: 10 mg
Half-life
Short (reported in clinical pharmacokinetic data)
Route
Subcutaneous (research)
Common use
Mitochondrial function research
Common vial sizes
10 mg · 30 mg · 50 mg
Storage
Store lyophilized powder refrigerated (2–8°C) and protected from light; once reconstituted, keep refrigerated and use within the timeframe supported by stability data.
Stacking notes
Sometimes referenced alongside other mitochondrial compounds such as MOTS-C or NAD+ in research discussions; combinations are not well characterized.

Reported side effects

Injection-site reactions (reported)Generally reported as well tolerated in trials
Regulatory note: Investigational; not approved as a therapeutic drug in Canada or the US. Studied in clinical trials for mitochondrial conditions. Research-grade material is not for human use.
Calculate a dose →SS-31 (Elamipretide) on The Peptide Guide →Deeper research reference: literature dose ranges, storage and handling, and where to source in Canada.

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Research-only labeling does not establish that a substance is safe, approved or appropriate for personal use. Consult a qualified healthcare professional about health decisions.